Albuterol
Drug · tier A · 8 trials (0 recruiting) · 12 publications · score 80.0
Azithromycin
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 80.0
Formoterol Fumarate
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 80.0
Glycopyrronium Bromide
Drug · tier A · 8 trials (0 recruiting) · 12 publications · score 80.0
Ipratropium Bromide
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 80.0
Tiotropium Bromide
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 80.0
Roflumilast
Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 77.5
Acetazolamide
Drug · tier A · 8 trials (0 recruiting) · 8 publications · score 74.0
Nicotine
Drug · tier A · 8 trials (1 recruiting) · 15 publications · score 73.5
Umeclidinium Bromide
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 68.0
N-acetylcysteine (NAC)
Supplement · tier C · 8 trials (1 recruiting) · 14 publications · score 63.5
Albuterol Sulfate
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 63.0
Ciprofloxacin
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 59.5
Arformoterol Tartrate
Drug · tier A · 8 trials (0 recruiting) · 4 publications · score 57.5
Indacaterol Maleate
Drug · tier A · 8 trials (0 recruiting) · 4 publications · score 57.0
Metoprolol
Drug · tier A · 7 trials (0 recruiting) · 5 publications · score 54.0
Prednisolone Sodium Phosphate
Drug · tier A · 8 trials (2 recruiting) · 0 publications · score 48.5
Olodaterol Hydrochloride
Drug · tier A · 2 trials (1 recruiting) · 0 publications · score 28.0
Panax ginseng
Supplement · tier C · 1 trials (0 recruiting) · 5 publications · score 21.0
Cordyceps sinensis
Supplement · tier C · 1 trials (0 recruiting) · 3 publications · score 19.0
Nanocurcumin
Supplement · tier C · 0 trials (0 recruiting) · 3 publications · score 17.0
L-Carnitine
Supplement · tier C · 1 trials (0 recruiting) · 2 publications · score 14.5
Research map, not treatment advice. Built 2026-10-07.